KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 74 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | +200.0% |
| Q3 2015 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |